ストックスクリーナーアプリを入手
21.03
0.27%
-0.0373
Innoviva Inc (INVA) 最新ニュース
Cantor Fitzgerald reiterates Innoviva stock rating at overweight - Investing.com
NewEdge Wealth LLC Acquires New Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. (NASDAQ:INVA) Receives Average Rating of "Hold" from Brokerages - MarketBeat
Innoviva (INVA) Snapshot: Posts a 2.23% Loss to $21.00 in Latest Trading; the Session Ends Within the Reported Technical Boundaries on the DayWedge Breakout - vinanet.vn
70,000 Shares in Innoviva, Inc. $INVA Purchased by Chase Investment Counsel Corp - MarketBeat
Innoviva’s Earnings Swing And Buyback Might Change The Case For Investing In Innoviva (INVA) - simplywall.st
Innoviva, Inc.: Target Price Consensus and Analysts Recommendations | INVA | US45781M1018 - marketscreener.com
Bank of America Corp DE Has $37.75 Million Stake in Innoviva, Inc. $INVA - MarketBeat
Innoviva (INVA) Holds Near $20.87 After Modest 0.29% GainSuperTrend - vinanet.vn
Innoviva Inc (INVA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Innoviva, Inc. (INVA) Stock Forecasts - Yahoo! Finance Canada
Innoviva (INVA) Holds Near $20.81 as Biopharma Royalty Stock Stays RangeboundVolatility Smile - vinanet.vn
HC Wainwright Issues Positive Forecast for Innoviva Earnings - MarketBeat
Three Innoviva therapies named finalists for Prix Galien award By Investing.com - Investing.com Australia
Three Innoviva therapies named finalists for Prix Galien award - Investing.com
Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award - Business Wire
Innoviva, Inc. (INVA) Stock Analysis: Uncovering a 69% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
How (INVA) Movements Inform Risk Allocation Models - Stock Traders Daily
Innoviva (INVA) Holds Steady at $20.68: Key Support and Resistance in FocusVolume Oscillator - vinanet.vn
Does Innoviva’s Q2 Loss and Buyback-Fueled EPS Shift Change The Bull Case For INVA? - webull.com
Innoviva stock price target reiterated at $46 by H.C. Wainwright - Investing.com Nigeria
Innoviva Stock Price Forecast. Should You Buy INVA? - StockInvest.us
Innoviva Inc (INVA) Stock News Today - TradingKey
How Innoviva’s Q2 Loss and Aggressive Buybacks Could Reshape Capital Allocation for INVA Investors - Yahoo Finance
Cantor Fitzgerald Maintains Innoviva(INVA.US) With Buy Rating, Raises Target Price to $34 - Moomoo
Innoviva (INVA) Stock Can Revenue Growth Offset A Sharp Profit Reversal - webull.com
Cantor Fitzgerald Lowers Innoviva (NASDAQ:INVA) Price Target to $34.00 - MarketBeat
INVA Q1 2026 Earnings: Significant EPS Miss Contrasts With Positive Stock MomentumTrough Earnings Signal - vinanet.vn
Innoviva: The Royalty Decline Is Real, But The Valuation Is Too Pessimistic (NASDAQ:INVA) - Seeking Alpha
BTIG Maintains Innoviva(INVA.US) With Buy Rating, Maintains Target Price $42 - Moomoo
Innoviva (NASDAQ:INVA) Announces Quarterly Earnings Results, Misses Expectations By $1.58 EPS - MarketBeat
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva (INVA) Q2 Earnings and Revenues Top Estimates - Yahoo Finance
Innoviva: Q2 Earnings Snapshot - Barchart.com
Innoviva, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Innoviva, Inc. Q2 2026: Revenue $119.6M, EPS $(1.14) — 10-Q Summary - tradingview.com
Innoviva reports Q2 2026 revenue $119.6M, net loss $83.4M on investment markdowns - TradingView
Earnings Flash (INVA) Innoviva, Inc. Reports Q2 Revenue $119.6M, vs. FactSet Est of $111.0M - marketscreener.com
Tranche Update on Innoviva, Inc.'s Equity Buyback Plan announced on November 5, 2025. - marketscreener.com
BRIEF-Innoviva Q2 Royalty Revenue USD 56.334 Million - TradingView
Innoviva, Inc. (INVA) Stock Analysis: Biotech Powerhouse With 70% Upside Potential - DirectorsTalk Interviews
Innoviva Inc. (INVA) Pulls Back 0.95% to $20.77 as Traders Eye Key Support ZoneSwing Entry Signals - dars.gov.et
Empowered Funds LLC Purchases 93,424 Shares of Innoviva, Inc. $INVA - MarketBeat
Innoviva, Inc. $INVA Shares Sold by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
INVA Q1 2026 Earnings: EPS Misses Consensus by Wide Margin, Stock Declines 1.18%Earnings Cycle Report - Vinanet
Innoviva, Inc. Revenue Breakdown – NASDAQ:INVA - TradingView
THRX5561968 Bond Coupon Profile — Rate & Payments - TradingView
Innoviva Inc (INVA) Institutional Confidence - TradingKey
Innoviva (INVA) Projected to Release Earnings on Wednesday - MarketBeat
Innoviva earnings up next: Can LYNX platform pivot pay off? By Investing.com - Investing.com Nigeria
Innoviva (INVA): Affordable Growth Stock at a Reasonable Valuation - ChartMill
Innoviva Inc (INVA) Valuation: PE, PB & Fair Value Analysis - TradingKey
INVA|Innoviva Inc|Price:20.970|Chg%:-0.250 - TradingKey
Innoviva Inc (INVA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Innoviva Inc (INVA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Innoviva Inc (INVA) Earnings Date & Reports & Earnings News - tradingkey.com
Thai FDA approves Dr Reddy’s gonorrhoea antibiotic - pharma.economictimes.indiatimes.com
Innoviva Inc (INVA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Innoviva Market Sentiment - Benzinga España
Innoviva Inc. (INVA) Gains Ground as Price Approaches Key Resistance LevelVWAP Bounce - dars.gov.et
Innoviva Inc (INVA) Balance Sheet - TradingKey
1.38%
0.61%
大文字化:
|
ボリューム (24 時間):